As per Future Market Insights’ latest industry analysis, the valuation for the global wheelchairs market was around US$ 5.5 Bn in 2021, and is projected to exhibit growth at a CAGR of close to 3.2% over the forecast period. Market Outlook: Data Points Market Insights Market Value 2021 US$ 5.5 Billion Market Value 2022 US$ …
Category Archives: Healthcare Trends
Rise in Cosmetic Dentistry is expected to propel the Growth of the Teeth Whitening Market | Future Market Insights
As per Future Market Insights’ latest revised industry analysis, the global teeth whitening market was valued at around US$ 6.4 Bn in 2021, and is expected to expand at a CAGR of 4.9% over the forecast period (2022-2032). Market Outlook: Data Points Market Insights Market Value 2021 USD 6.4 Bn Market Value 2022 USD 6.6 …
Rosai-Dorfman Disease Therapeutics Market is expected to grow with a 6.9% CAGR during 2023 to 2033
During the forecast period 2023 to 2033, the Rosai-Dorfman Disease (RDD) Therapeutics Market is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Rosai-Dorfman Disease (RDD) Therapeutics is expected to rise up to a market valuation of US$ 839.95 Million. The global …
Whim Syndrome Management Market is expected to reach US$ 17.91 Million by 2033
The global Whim Syndrome Management Market is predicted to generate a market value of US$ 10 million in 2023 and a market value of US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. Between 2018 and 2022, the market for Whim Syndrome Management grew at a CAGR of 4%. The …
Continue reading “Whim Syndrome Management Market is expected to reach US$ 17.91 Million by 2033”
Atypical Hemolytic Uremic Syndrome Treatment Market to Register 4.9% CAGR from 2023 to 2033
During the forecast period 2023 to 2033, the atypical hemolytic uremic syndrome (ahus) treatment market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Atypical hemolytic uremic syndrome (ahus) treatment is expected to rise up to a market valuation of US$ …
Cell and Gene Therapy Manufacturing Market is projected to increase at a CAGR 29% from 2023 to 2033
The global cell and gene therapy manufacturing market is worth US$ 19.3 Billion as of now and expected to reach US$ 240 Billion by the year 2033 at a staggering CAGR of 29% between 2023 and 2033. The changing landscape of treating chronic ailments through advanced therapies is the key factor driving the cell and …
Clinical Trials Market is expected to reach US$ 177.7 Billion by 2033
The global clinical trials market is anticipated to augment at a flourishing CAGR of 4.41% over the forecast period from 2023 to 2033. The global market is expected to enjoy a valuation of US$ 115.4 Billion by the end of the year 2023 and reach a valuation of US$ 177.7 Billion by the year 2033. …
Continue reading “Clinical Trials Market is expected to reach US$ 177.7 Billion by 2033”
Viral Vector Development Market to Reach US$ 4.1 Billion Valuation by 2033
The global viral vector development market is anticipated to flourish at a phenomenal CAGR of 18.7% over the assessment period from 2023 to 2033. The global market is set to enjoy a valuation of US$ 730.7 Million by the end of the year 2023 to reach a valuation of US$ 4.1 Billion by the year …
Continue reading “Viral Vector Development Market to Reach US$ 4.1 Billion Valuation by 2033”
Transcatheter Heart Valve Replacement (TAVR) Market is expected to reach a valuation of US$ 25.4 Billion by 2033 | FMI
The Transcatheter Heart Valve Replacement (TAVR) Market is expected to grow at a 12% CAGR between 2022 and 2032. The report focuses on providing key insights into various market features such as demand, product developments, revenue generation, and sales in the Transcatheter Heart Valve Replacement (TAVI) market. The study provides a detailed analysis of market …
Low-Grade Glioma Therapeutics Market is expected to garner a market value of US$ 1038 Million in 2023
During the forecast period 2023 to 2033, the Low-grade Glioma therapeutics market is expected to grow at a value of 4.57% CAGR, according to Future Market Insights. By the year 2033, the global market for Low-grade Glioma therapeutics is expected to rise up to a market valuation of US$ 1515.47 Million. Growth of the market can be …